Zhan Xu

9PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniquesMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2025
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

Zhan Xu, Zijian Zhou, Jong Bum Son

|Nov 06, 2024
Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

Casey E Stowers, Chengyue Wu, Zhan Xu

|Jan 31, 2024
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.

Benjamin C Musall, David E Rauch, Rania M M Mohamed

|Oct 14, 2023
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer.

Zhan Xu, David E Rauch, Rania M Mohamed

|Feb 25, 2023
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI.

Bikash Panthi, Beatriz E Adrada, Rosalind P Candelaria

|Dec 05, 2022
Model-constrained reconstruction accelerated with Fourier-based undersampling for hyperpolarized [1-13 C] pyruvate imaging.

Zhan Xu, Keith A Michel, Christopher M Walker

Pageof 2

Frequent Collaborators

3 joint publications

Debu Tripathy

3 joint publications

Rania M Mohamed

2 joint publications

Christopher M Walker

2 joint publications

Jeremy W Gordon